Oppenheimer Starts Olema Pharmaceuticals (OLMA) at Outperform, 'bullish ahead of 2H23 data'

July 20, 2023 4:02 PM EDT Send to a Friend
(Updated - July 20, 2023 4:03 PM EDT)

Oppenheimer analyst Matthew Biegler initiates coverage on Olema Pharmaceuticals (NASDAQ: OLMA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login